Barakat R - Search Results

1

Dose escalation of paclitaxel with high-dose cyclophosphamide, with analysis of progenitor-cell mobilization and hematologic support of advanced ovarian cancer patients receiving rapidly sequenced high-dose carboplatin/cyclophosphamide courses.

Fennelly D, Schneider J, Spriggs D, Bengala C, Hakes T, Reich L, Barakat R, Curtin J, Moore MA, Hoskins W, et al. Fennelly D, et al. Among authors: barakat r. J Clin Oncol. 1995 May;13(5):1160-6. doi: 10.1200/JCO.1995.13.5.1160. J Clin Oncol. 1995. PMID: 7537799 Clinical Trial.

2

Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial.

Hensley ML, Maki R, Venkatraman E, Geller G, Lovegren M, Aghajanian C, Sabbatini P, Tong W, Barakat R, Spriggs DR. Hensley ML, et al. Among authors: barakat r. J Clin Oncol. 2002 Jun 15;20(12):2824-31. doi: 10.1200/JCO.2002.11.050. J Clin Oncol. 2002. PMID: 12065559 Clinical Trial.

3

Intraperitoneal chemotherapy for ovarian carcinoma: results of long-term follow-up.

Barakat RR, Sabbatini P, Bhaskaran D, Revzin M, Smith A, Venkatraman E, Aghajanian C, Hensley M, Soignet S, Brown C, Soslow R, Markman M, Hoskins WJ, Spriggs D. Barakat RR, et al. J Clin Oncol. 2002 Feb 1;20(3):694-8. doi: 10.1200/JCO.2002.20.3.694. J Clin Oncol. 2002. PMID: 11821450

4

Phase I trial of intraperitoneal taxol: a Gynecoloic Oncology Group study.

Markman M, Rowinsky E, Hakes T, Reichman B, Jones W, Lewis JL Jr, Rubin S, Curtin J, Barakat R, Phillips M, et al. Markman M, et al. Among authors: barakat r. J Clin Oncol. 1992 Sep;10(9):1485-91. doi: 10.1200/JCO.1992.10.9.1485. J Clin Oncol. 1992. PMID: 1355523 Clinical Trial.

5

Phase 2 trial of chronic low-dose oral etoposide as salvage therapy of platinum-refractory ovarian cancer.

Markman M, Hakes T, Reichman B, Curtin J, Barakat R, Rubin S, Jones W, Lewis JL Jr, Almadrones L, Hoskins W. Markman M, et al. Among authors: barakat r. J Cancer Res Clin Oncol. 1992;119(1):55-7. doi: 10.1007/BF01209489. J Cancer Res Clin Oncol. 1992. PMID: 1400568 Clinical Trial.

6

Phase 2 trial of intraperitoneal carboplatin and etoposide as salvage treatment of advanced epithelial ovarian cancer.

Markman M, Reichman B, Hakes T, Rubin S, Jones W, Lewis JL Jr, Barakat R, Curtin J, Almadrones L, Hoskins W. Markman M, et al. Among authors: barakat r. Gynecol Oncol. 1992 Dec;47(3):353-7. doi: 10.1016/0090-8258(92)90139-a. Gynecol Oncol. 1992. PMID: 1473749 Clinical Trial.

7

Exploring the use of chronic low-dose oral etoposide in ovarian cancer: is there a role for this "new drug" in the management of platinum-refractory disease?

Markman M, Hakes T, Reichman B, Barakat R, Curtin J, Jones W, Lewis JL Jr, Rubin S, Almadrones L, Hoskins W. Markman M, et al. Among authors: barakat r. Semin Oncol. 1992 Dec;19(6 Suppl 14):25-7. Semin Oncol. 1992. PMID: 1488652 Clinical Trial.

8

Impact on survival of surgically defined favorable responses to salvage intraperitoneal chemotherapy in small-volume residual ovarian cancer.

Markman M, Reichman B, Hakes T, Lewis JL Jr, Jones W, Rubin S, Barakat R, Curtin J, Almadrones L, Hoskins W. Markman M, et al. Among authors: barakat r. J Clin Oncol. 1992 Sep;10(9):1479-84. doi: 10.1200/JCO.1992.10.9.1479. J Clin Oncol. 1992. PMID: 1517791 Clinical Trial.

9

Salvage intraperitoneal therapy of small-volume residual ovarian cancer: impact of pretreatment finding of peritoneal carcinomatosis on the surgical complete response rate.

Markman M, Reichman B, Hakes T, Barakat R, Curtin J, Rubin S, Jones W, Lewis JL Jr, Almadrones L, Hoskins W. Markman M, et al. Among authors: barakat r. J Cancer Res Clin Oncol. 1992;118(3):235-7. doi: 10.1007/BF01410140. J Cancer Res Clin Oncol. 1992. PMID: 1548290

10

Association between pretreatment CA-125 levels and surgically documented complete responses in patients with ovarian cancer treated with second-line intraperitoneal therapy.

Markman M, Reichman B, Hakes T, Curtin J, Barakat R, Rubin S, Jones W, Lewis JL Jr, Almadrones L, Hoskins W. Markman M, et al. Among authors: barakat r. J Cancer Res Clin Oncol. 1992;118(5):391-4. doi: 10.1007/BF01294446. J Cancer Res Clin Oncol. 1992. PMID: 1583069

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

643 results

Search Page

Filters